ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.

Rory J McCrimmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.